Governance for Health Security: Lessons from Nigeria’s PVAC in Manufacturing Local Malaria Commodities

Background: The Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) was established to address systemic barriers to domestic manufacturing by providing a high-level governance mechanism that aligns national health-security priorities with industrial policy objectives. This paper analyses PVAC as an emerging governance model for accelerating local production of malaria commodities, including ACTs, APIs, LLINs, and RDTs. Methods: The study undertook a structured review of seven national technical briefs produced under the Enhancing Local Manufacturing and Supply Chain Management Project, an initiative of PVAC and the National Malaria Elimination Programme (NMEP), supported by the World Bank IMPACT Project. These were complemented by a national manufacturing readiness assessment and relevant regulatory and industrial policy documents. Document synthesis was appropriate given PVAC’s system-level mandate and enabled analysis of governance coordination, market-shaping interventions, and regulatory and capacity-strengthening reforms across institutions. Results: Evidence from the technical briefs and readiness assessment indicates that PVAC has generated tangible governance, regulatory, and market-shaping outcomes with implications for market predictability and manufacturing readiness. PVAC established multi-agency coordination mechanisms and facilitated the development of national roadmaps for LLINs, RDTs, ACTs, and API localisation. It introduced Nigeria’s first tiered procurement eligibility pathway, harmonised LLIN and RDT specifications, and supported national demand-consolidation modelling, improving clarity for manufacturers. Regulatory coordination strengthened GMP alignment, quality-control systems, and PQ-readiness pathways, while financing coordination linked manufacturers to public and development finance institutions using roadmap-aligned demand forecasts. Conclusion: PVAC’s governance model reflects international experiences in India, Ethiopia, and Bangladesh, where centralised coordination accelerated pharmaceutical industrialisation and strengthened health security. Beyond Nigeria, PVAC offers transferable lessons for other low- and middle-income countries seeking to leverage governance coordination, procurement reform, and regulatory alignment to advance pharmaceutical self-sufficiency and resilience against global supply shocks.

Authors

Institutions

Publication Details

Journal
Journal of Advances in Medicine and Medical Research
Published
2026-01-07
DOI
https://doi.org/10.9734/jammr/2026/v38i16046
Primary Topic
Pharmaceutical Quality and Counterfeiting
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Governance for Health Security: Lessons from Nigeria’s PVAC in Manufacturing Local Malaria Commodities

Okefu Oyale Okoko, Nnenna C. Ogbulafor, Oluwatoyin Karimu, Tochukwu Osuji et al.
Journal of Advances in Medicine and Medical Research
Pharmaceutical Quality and Counterfeiting
article

Governance for Health Security: Lessons from Nigeria’s PVAC in Manufacturing Local Malaria Commodities

Okefu Oyale Okoko, Nnenna C. Ogbulafor, Oluwatoyin Karimu, Tochukwu Osuji, Ezire Onoriode, Nnenna Mba-Oduwusi, Bolaji Usman Aduagba, Abdu Mukhtar, Muhammad Balarabe
article en

Abstract

Background: The Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) was established to address systemic barriers to domestic manufacturing by providing a high-level governance mechanism that aligns national health-security priorities with industrial policy objectives. This paper analyses PVAC as an emerging governance model for accelerating local production of malaria commodities, including ACTs, APIs, LLINs, and RDTs. Methods: The study undertook a structured review of seven national technical briefs produced under the Enhancing Local Manufacturing and Supply Chain Management Project, an initiative of PVAC and the National Malaria Elimination Programme (NMEP), supported by the World Bank IMPACT Project. These were complemented by a national manufacturing readiness assessment and relevant regulatory and industrial policy documents. Document synthesis was appropriate given PVAC’s system-level mandate and enabled analysis of governance coordination, market-shaping interventions, and regulatory and capacity-strengthening reforms across institutions. Results: Evidence from the technical briefs and readiness assessment indicates that PVAC has generated tangible governance, regulatory, and market-shaping outcomes with implications for market predictability and manufacturing readiness. PVAC established multi-agency coordination mechanisms and facilitated the development of national roadmaps for LLINs, RDTs, ACTs, and API localisation. It introduced Nigeria’s first tiered procurement eligibility pathway, harmonised LLIN and RDT specifications, and supported national demand-consolidation modelling, improving clarity for manufacturers. Regulatory coordination strengthened GMP alignment, quality-control systems, and PQ-readiness pathways, while financing coordination linked manufacturers to public and development finance institutions using roadmap-aligned demand forecasts. Conclusion: PVAC’s governance model reflects international experiences in India, Ethiopia, and Bangladesh, where centralised coordination accelerated pharmaceutical industrialisation and strengthened health security. Beyond Nigeria, PVAC offers transferable lessons for other low- and middle-income countries seeking to leverage governance coordination, procurement reform, and regulatory alignment to advance pharmaceutical self-sufficiency and resilience against global supply shocks.

Journal of Advances in Medicine and Medical ResearchVol. 38(1)
University of North Carolina Health Care (US), Malaria Consortium (GB), Management Sciences for Health (US), AIDS Prevention Initiative in Nigeria (NG), World Health Organization - Nigeria (NG), University of Abuja (NG)
Partnerships for the goals
Openalex Percentile: Top 93%
Pharmaceutical Quality and Counterfeiting
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.